Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by TOMODA, H.
Right arrow Articles by ICHINO, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOMODA, H.
Right arrow Articles by ICHINO, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 13:353-360 (1983)
© 1983 Foundation for Promotion of Cancer Research

research-article

Diagnostic Value of 5'-Nucleotide Phosphodiesterase Isozyme-V for Detection of Liver Metastasis in Patients with Gastro-Intestinal Cancer

HIROTSUGU TOMODA, M.D., MOTONOSUKE FURUSAWA, M.D. and MOTONOBU ICHINO, Ph.D.*

Department of Gastrointestinal Surgery, National Kyushu Cancer Center Fukuoka
*Kitasato Biochemical Laboratories Sagamihara, Kanagawa

Reprint requests: Hirotsu Tomoda, M.D., Department of Surgery, National Kyushu Cancer Center, 595, Notame, Minami-ku, Fukuoka 815, Japan.

Received February 19, 1983; Serum 5'-nucleotide phosphodiesterase isozyme-V (5'-NPDase-V) in 200 patients with various gastrointestinal disorders including 178 malignant cases and 22 benign cases was measured, and the usefulness and limitations of this test for the detection of liver metastasis were studied. Of the laboratory tests performed in the 44 patients with liver metastasis, 5'-NPDase-V and carcino-embryonic antigen (CEA) (> 10.0ng/ml) were positive in 68.2%. This rate was higher than that for any other laboratory test. Positive 5'-NPDase-V assays were found in 46.2% of the patients with H1 metastasis, 70% with H2 and 81% with H3. This test was considered to be useful diagnostically, when liver metastasis was of more than a certain degree. 5'-NPDase-V was positive in 85.7% of the patients who had liver metastasis and had a serum total bilirubin value of more than 2.5 mg/dl. Particular attention should be paid to the evaluation of this test when jaundice is present. In eight of the patients with liver metastasis, CEA (> 10.0 ng/ml) was negative, whereas 5'-NPDase-V was positive. One or both of these two markers were positive in 86.4%. A combination assay of these two markers was considered to be more useful than 5'-NPDase-V alone as a screening test for the detection of liver metastasis.

In one patient who underwent hepatic lobectomy for recurrence of cancer in the liver, 5'-NPDase-V and CEA were measured before and after the operation. CEA returned to normal immediately after the operation, whereas 5'-NPDase-V became negative five months after the operation. It is presumed that the changes in 5'-NPDase-V after hepatic lobectomy were related to liver regeneration.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.